NENU2PHAR will contribute to the creation of new cross-sector interconnection in the bio-based economy by means of the interconnection between the aquatic biomass production sector and the plastic production sector. This cross-sector interconnection has been established as the core concept of NENU2PHAR, the production of PHA biopolymer based on microalgae biomass achieved. The NENU2PHAR value chain addresses new (or optimised) bio-based value chains, the PHA-based bioplastic products from a biological source have been transformed into plastic compounds, the End of Life of these products is promising in terms of biodegradation. The value chain is being structured. The PHA biopolymer products under development in NENU2PHAR have addressed new bio-based materials, at this point the different formulations developed allow the production of the 2 first prototypes of 3D printing and plastic tray products. The TRL gain is being progressively addressed. Progresses have been done on the technical steps of the value chain, carbon feedstock from microalgae biomass is already running in semi-industrial pilot scale. Cell disruption pre-treatments for microalgae and bacteria have been identified and are developped at lab-scale, PHA extraction methods and protocols have been identified and implemented in lab context for PHA polymler. Functionalisation of PHA are being improved by developing blends based on biodegradable polymers and using the compounding process. Compounding of PHAs has been achieved using different plastic transformation technologies like the injection moulding process, a flexible or rigid film extrusion, the filament extrusion, or the surface texturization by injection moulding. PHA formulating and textile extrusion has moved forward by means of the blending of PHA with other polymers and, finally, the end of life by biodegradation of these bioplastic is being demonstrated. These products will increase the environmental sustainability of materials for high-volume consumer products, It is expected that the progress of NENU2PHAR will foster the future market uptake of the bio-based materials for high-volume consumer products and will increase the income and business opportunities for stakeholders and actors (including primary producers) in the bio-based sectors. NENU2PHAR results can create new job opportunities in the bio-based sector, particularly the rural, coastal and/or urban areas at the same time that bioplastic production capacities in Europe are enhanced.